This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Universitat Heidelberg. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations by Stefan Kallenberger in Myocardial Conductivity
Introduction
Stefan Kallenberger is an innovative inventor based in Heidelberg, Germany. He has made significant contributions to the field of cardiology through his research and inventions. His work focuses on improving the electrical conduction system of the heart, particularly in preventing arrhythmias.
Latest Patents
Stefan Kallenberger holds a patent for a method to prevent the propagation of irregular electromechanical waves in the myocardium by creating lines of increased tissue conductivity. This invention relates to compositions, methods, and devices aimed at preventing irregular electromechanical waves that can lead to pathological conditions such as arrhythmia. The patent details the use of substances with high conductivity, such as carbon nanotube suspensions or metal nanowire suspensions, which are injected into the myocardium to restore the impairment of the heart's electrical conduction system.
Career Highlights
Kallenberger is affiliated with the prestigious Universitat Heidelberg, where he conducts his research and develops his inventions. His work has garnered attention for its potential to significantly improve cardiac health and treatment options for patients suffering from arrhythmias.
Collaborations
Stefan Kallenberger collaborates with notable colleagues, including Constanze Schmidt and Hugo Katus. Their combined expertise contributes to advancing research in the field of cardiology and enhancing the effectiveness of treatments for heart conditions.
Conclusion
Stefan Kallenberger's innovative approach to improving myocardial conductivity represents a significant advancement in cardiac health. His patent and ongoing research have the potential to transform treatment options for patients with arrhythmias.